Glucose and lipid metabolism in patients treated with atypical and conventional antipsychotic medication

被引：0
|
作者：
Lindenmayer, J [1 ]
Smith, RC [1 ]
Bark, N [1 ]
Khandat, A [1 ]
机构：
[1] Manhattan Psychiat Ctr, Psychopharmacol Res Unit, New York, NY USA
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80182-2
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：361 / 361
页数：1
相关论文
共 50 条
  • [1] Relationship of tardive dyskinesia and EPS to glucose and lipid metabolism in patients treated conventional and atypical antipsychotic medications
    Smith, RC
    Bark, N
    Vaidhyanathaswamy, S
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S254 - S254
  • [2] Tardive dyskinesia, EPS symptoms, and glucose and lipid metabolism in patients treated with conventional and atypical antipsychotics
    Smith, RC
    Bark, N
    Lindenmayer, JP
    Warner-Cohen, J
    Vaidhyanathaswamy, S
    Hopkins, M
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 93S - 93S
  • [3] Abnormalities in glucose metabolism in patients with schizophrenia treated with atypical antipsychotic medications
    Elias, Alan N.
    Hofflich, Heather
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (02): : 98 - 104
  • [4] Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism
    Dwyer, DS
    Lu, XH
    Bradley, RJ
    BRAIN RESEARCH, 2003, 971 (01) : 31 - 39
  • [5] Hypothermia in 2 patients treated with atypical antipsychotic medication
    Parris, C
    Mack, JM
    Cochiolo, JA
    Steinmann, AF
    Tietjen, J
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 (01) : 61 - 63
  • [6] Glucose metabolism in patients with schizophrenia treated with antipsychotic agents
    Fukui, Naoki
    Suzuki, Yutaro
    Sawamura, Kazushi
    Sugai, Takuro
    Watanabe, Junzo
    Ono, Shin
    Murata, Shigeo
    Suzuki, Yuji
    Someya, Toshiyuki
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2007, 22 (05) : A10 - A10
  • [7] Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication A review
    Hannu Koponen
    Kaisa Saari
    Markku Savolainen
    Matti Isohanni
    European Archives of Psychiatry and Clinical Neuroscience, 2002, 252 : 294 - 298
  • [8] Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication - A review
    Koponen, H
    Saari, K
    Savolainen, M
    Isohanni, M
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2002, 252 (06) : 294 - 298
  • [9] Prevalence and predictors of lipid and glucose monitoring among commercially insured patients treated with atypical antipsychotic agents
    Haupt, Dan W.
    Rosenblatt, Lisa C.
    Kim, Edward
    Baker, Ross A.
    Whitehead, Richard
    Newcomer, John W.
    DIABETES, 2008, 57 : A346 - A347
  • [10] The comparison of glucose and lipid metabolism parameters in drug-naive, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
    Wu, Xiaoli
    Huang, Zeping
    Han, Hongying
    Zhong, Zhiyong
    Gan, Zhaoyu
    Guo, Xiaofeng
    Diao, Feici
    Han, Zili
    Zhao, Jingping
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 1361 - 1368
12345